​

Bellevue Life Sciences Acquisition (BLAC) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Bellevue Life Sciences Acquisition Revenue Highlights

Latest Revenue (Y)

$2.91M

Latest Revenue (Q)

$484.06K

Bellevue Life Sciences Acquisition Revenue by Period

Bellevue Life Sciences Acquisition Revenue by Year

DateRevenueChange
2025-12-31$2.91M100.00%
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31--

Bellevue Life Sciences Acquisition generated $2.91M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Bellevue Life Sciences Acquisition Revenue by Quarter

DateRevenueChange
2026-03-31$484.06K26.96%
2025-12-31$381.27K-39.26%
2025-09-30$627.75K-44.72%
2025-06-30$1.14M49.16%
2025-03-31$761.27K100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--

Bellevue Life Sciences Acquisition generated $484.06K in revenue during Q1 2026, up 26.96% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Bellevue Life Sciences Acquisition Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BLACBellevue Life Sciences Acquisition$2.91M$484.06K
JVSAJV SPAC Acquisition Corp. Class A Ordinary Share--
RFACRF Acquisition--
BNIXBannix Acquisition--

BLAC Revenue FAQ

What is Bellevue Life Sciences Acquisition’s yearly revenue?

Bellevue Life Sciences Acquisition's yearly revenue for 2025 was $2.91M, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. BLAC's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022.

What is Bellevue Life Sciences Acquisition’s quarterly revenue?

Bellevue Life Sciences Acquisition's quarterly revenue for Q1 2026 was $484.06K, a 26.96% increase from the previous quarter (Q4 2025), and a -36.41% decrease year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $381.27K, a -39.26% decrease from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). BLAC's quarterly revenue for Q3 2025 was $627.75K, a -44.72% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024).

What is Bellevue Life Sciences Acquisition’s revenue growth rate?

Bellevue Life Sciences Acquisition's revenue growth rate for the last 3 years (2023-2025) was 0%, and for the last 5 years (2021-2025) was 0%.